Biofrontera Inc. Warrants
BFRIW
About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Employees: 93
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
49% more capital invested
Capital invested by funds: $12.4K [Q1] → $18.5K (+$6.12K) [Q2]
9.53% more ownership
Funds ownership: 2.28% [Q1] → 11.82% (+9.53%) [Q2]
17% less funds holding
Funds holding: 6 [Q1] → 5 (-1) [Q2]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Financial journalist opinion
We haven’t received any recent news articles for BFRIW